| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $44.3M | -5.2% |
| Cost of Revenue | $18.8M | +3.9% |
| R&D Expense | $3.8M | -24.0% |
| SG&A Expense | $51.6M | -21.7% |
| Operating Income | -$60.8M | +21.7% |
| Pre-tax Income | -$73.1M | +26.8% |
| Income Tax | -$14K | +40.9% |
| Net Income | -$72.9M | +26.9% |
| EPS (Basic) | -$1.04 |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.8M | -56.8% |
| Accounts Receivable | $2.6M | -28.1% |
| Inventory | $203K | +186.6% |
| Current Assets | $27.0M | -45.9% |
| Total Assets | $32.6M | -44.0% |
| Current Liabilities | $56.9M | -13.3% |
| Long-term Debt | $140K | -90.5% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.1M | -17.6% |
| Investing Cash Flow | -$116K | +98.3% |
| Financing Cash Flow | $11.7M | -45.6% |
| +54.0% |
| EPS (Diluted) | -$1.04 | +54.0% |
| Total Liabilities |
| $58.3M |
| -15.1% |
| Stockholders' Equity | -$25.1M | -148.9% |